Whetstone Capital Advisors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
N
Whetstone Capital Advisors's DXCM Position: Q4 2024 in Review
Whetstone Capital Advisors sold out of DexCom (DXCM) in Q4 2024, closing a stake of 70,065 shares — an estimated $4.7M sold.
Whetstone Capital Advisors first reported a position in DXCM in Q4 2023 and held it in 4 quarters. The position peaked at $4.7M in Q3 2024. 950 funds tracked by Wall St. Rank hold DXCM as of Q4 2024.
- Whetstone Capital Advisors reported no remaining DexCom position as of Q4 2024 after selling out during the quarter.
- Whetstone Capital Advisors sold 70,065 DexCom shares in Q4 2024, an estimated $4.7M.
- Whetstone Capital Advisors first reported a position in DexCom in Q4 2023 and held it in 4 quarters.
- Whetstone Capital Advisors's DexCom position peaked at $4.7M in Q3 2024.
- 950 funds tracked by Wall St. Rank held DexCom as of Q4 2024.
Based on Whetstone Capital Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.